-
Written by
Bhavya Bhambani
Content Writer, 9M India
-
Reviewed by
Manish Agrawal
MD, 9M India Limited
-
Fact-checked by
Manish Shah
Plant Head, 9M India
Contract Manufacturing Pharma Companies India – Industry Context
As per Pharmexcil (2024), India’s pharmaceutical contract manufacturing industry is estimated to be worth $2.8 billion and is growing at 10-12 per cent per annum. The sector is a mix of regulated market CDMOs (US/EU) and semi-regulated market contract manufacturers (Africa/Middle East). International buyers’ key differentiator: Regulated market CDMOs (Jubilant, Piramal, and Divi’s) require minimum orders of multi-million units and are set up for US/EU compliance – not available for Africa or Middle East programme sizes.
From The Pharma Guide
6 things to check before choosing an injection manufacturer in India
WHO-GMP certificate expiry, molecule-level DCGI approval, sample COA availability within 24 hours,
export references in your target country, cleanroom grade classification, and documentation
turnaround - the buyer's six-point verification checklist.
Read the full checklist
#1 CONTRACT MANUFACTURING PHARMA COMPANY IN INDIA 2026
Need contract manufacturing?
Share your molecule, dosage form, and target market. We confirm manufacturing capability, pricing, and all export documentation within 24 hours.
-
200+ molecules — sterile injectables, capsules, tablets, syrups, eye drops, topicals
-
MOQs built for Africa & Middle East programmes, from 10,000 to 10 lakh units
-
MOQs built for Africa & Middle East programmes, from 10,000 to 10 lakh units
-
Active export to Kenya, Nigeria, UAE and 15+ countries
Talk to 9M India
Talk to 9M India
Looking for a WHO-GMP certified manufacturing partner with full documentation?
Share your molecule, strength, and target market. We confirm manufacturing capability, pricing, and all export documentation within 24 hours.
WHO-GMP certified · DCGI approved · 15+ export countries · Birkoni, Chhattisgarh · Est. 2009 · Reply guaranteed within 24 hours